The four-symptom screen for active tuberculosis (TB) is less likely to detect active TB in people taking antiretroviral therapy (ART) and may be improved by the additional use of a chest x-ray, according to a World Health Organisation, systematic review and meta-analysis.

A nanochannel delivery implant can deliver pre-exposure prophylaxis (PrEP) antiretrovirals drugs subcutaneously, according to study results.

The rate of adherence to HIV therapy in North America is a mere 55%. A study found that side effects, dosing regimen, poor partner support, depressive symptoms, and alcohol consumption all play a role in non-adherence.

New data show that dolutegravir in combination with lamivudine could be an option both for treatment-naїve patients and and as a switch strategy for patients with viral suppression

People on methadone maintenance treatment spent less time with a detectable viral load above 1,500 copies/ml, potentially reducing the risk of HIV transmission.